Using tranexamic acid for an additional 24 hours postoperatively in hip and knee arthroplasty saves money: a cost analysis from the TRAC-24 randomized control trial

AIMS: Tranexamic acid (TXA) is now commonly used in major surgical operations including orthopaedics. The TRAC-24 randomized control trial (RCT) aimed to assess if an additional 24 hours of TXA postoperatively in primary total hip (THA) and total knee arthroplasty (TKA) reduced blood loss. Contrary...

Descripción completa

Detalles Bibliográficos
Autores principales: Karayiannis, Paul N., Agus, Ashley, Bryce, Leanne, Hill, J. C., Beverland, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The British Editorial Society of Bone & Joint Surgery 2022
Materias:
Arthroplasty
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9350706/
https://www.ncbi.nlm.nih.gov/pubmed/35816170
http://dx.doi.org/10.1302/2633-1462.37.BJO-2021-0213.R1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9350706/
https://www.ncbi.nlm.nih.gov/pubmed/35816170
http://dx.doi.org/10.1302/2633-1462.37.BJO-2021-0213.R1

Ejemplares similares